2021 Experiential Internship Bioinformatics
Posted on: 18 Mar 2021
Chicago, IL
Job Description
About AbbVie
AbbVies mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on peoples lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, womens health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
We have an exciting intern opportunity for an undergraduate bioinformatician or computational biologist to leverage linux shell commands with R programing to maintain and optimize semi-automated gene expression profile workflow from NCBI GEO and ArrayExpress microarray repositories. Work for this project will focus on public Affymetrix Mouse 430 2.0 gene expression microarrays which will be used in project tissue and disease model prioritization. This includes refining automatic quality control, automatic normalization, and automated single-sample gene set enrichment scoring to support project model prioritization.
Qualifications
Preferred Qualifications:
* Technical competency, especially recording hours and preserving work/code
* Strong communication skills, especially presentation of Power Point summary slide
* Fluency in relevant programming languages, especially R and linux shell, for the analysis of high-throughput gene expression transcriptomics, enrichment analysis, proteomics, metabolomics, and signaling network analysis
* Candidates with experience analyzing and interpreting gene expression data for understanding disease mechanisms and model organism prioritization are highly desired
* A background in analyzing and comparing fibrotic diseases and metabolic diseases across multiple tissues from affected patients and mouse models is highly desired
Minimum Qualifications:
* Minimum GPA = 3.0/4.0
* Returning to university for at least one semester
* Currently enrolled in university, pursuing a bachelors degree with a major in Biochemistry, Biology, Computer Science, Data Analytics, Neurobiology, Psychology, or a related field
* Demonstrated leadership skills (i.e. extracurricular activities or projects)
* Must be authorized to work in the US on a permanent basis without requiring sponsorship
Significant Work Activities
Continuous sitting for prolonged periods (more than 2 consecutive hours in an 8 hour day)
Travel
No
Job Type
Internship
Schedule
Full-time
Job Level Code
IC
Equal Employment Opportunity
At AbbVie, we value bringing together individuals from diverse backgrounds to develop new and innovative solutions for patients. As an equal opportunity employer we do not discriminate on the basis of race, color, religion, national origin, age, sex (including pregnancy), physical or mental disability, medical condition, genetic information gender identity or expression, sexual orientation, marital status, protected veteran status, or any other legally protected characteristic.
AbbVie
Chicago, IL
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström’s macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.
It also provides KALETRA, an anti-human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; NORVIR, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and SYNAGIS to prevent respiratory syncytial virus infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron to treat prostate cancer, endometriosis, and central precocious puberty, as well as anemia.
Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson’s disease; Sevoflurane, an anesthesia product; and ORILISSA, a non-peptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain. It has collaborations with Alector, Inc.; Janssen Biotech, Inc.; Galapagos; Bristol-Myers Squibb Company; and Calico Life Sciences LLC. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
-
IndustryBiopharmaceuticals
-
No. of Employees30, 000
-
Website
-
Jobs Posted3263
